GHK-Cu: Research Overview

The short version

GHK-Cu is a copper peptide. It is three amino acids — glycine, histidine, lysine, the small building blocks that link into proteins — bound tightly to a copper atom. The body makes it naturally. It shows up in blood, saliva, and skin, and the amount falls as people age ^[4].

Researchers study GHK-Cu mainly for one thing: collagen. Collagen is the structural protein that keeps skin firm and wounds closing properly. In lab and small human studies, GHK-Cu turns up collagen production and several related repair signals ^[1][4][6][7]. A six-month trial also linked a GHK-containing formula to more hair growth than placebo in men with pattern hair loss ^[3].

Topical GHK-Cu — sold as Copper Tripeptide-1 — is a legal cosmetic ingredient. Injecting it or taking it systemically is not approved for any purpose and has almost no human safety data behind it. This page separates what was studied from what was not, and cites every number to its source.

What it is

GHK-Cu is the copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine. The copper sits chelated to the peptide backbone — bound through the histidine ring and two nitrogen atoms from the glycine end — leaving the lysine side free. The molecular formula is C14H23CuN6O4+.

The GHK sequence is not invented; it exists inside human type I collagen and a related repair protein, SPARC. GHK-Cu is the form the body releases when tissue breaks down — a signal fragment, not a foreign molecule.

Human plasma GHK runs around 200 nanograms per milliliter at age 20 and falls to roughly 80 nanograms per milliliter by age 60 ^[4]. That decline tracks the slowdown in tissue-repair capacity that comes with age, though correlation is not the same as a proven causal mechanism.

How it works

GHK-Cu works two ways at once: as a copper carrier and as a signal. At very low, picomolar-to-nanomolar concentrations, it acts directly on skin fibroblasts — the cells that make collagen, elastin, and the gel-like glycosaminoglycans that give skin its structure — and pushes them to synthesize more of each ^[1][4][7]. Fibroblast collagen output rose in a dose-dependent way starting around 10^-12 to 10^-11 M and peaking near 10^-9 M, independent of any change in cell number ^[7].

The copper ion itself matters. It enables an enzyme called lysyl oxidase to cross-link new collagen and elastin fibers into a stable matrix, and it gives GHK-Cu antioxidant activity similar to the body's own superoxide-dismutase enzyme.

At a broader level, gene-expression studies report that GHK shifts activity in roughly 31.2% of human genes at a 50%-or-greater change threshold — about 2,100 genes at that cutoff, not the often-repeated 'thousands' figure, which is an extrapolation beyond what the data directly show ^[2]. The genes affected skew toward wound repair, DNA repair, antioxidant defense, and protein-quality-control pathways, while suppressing inflammatory NF-kB signaling ^[2].

What the research shows

Anti-wrinkle efficacy and delivery. A 2025 review of GHK-Cu as a topical anti-wrinkle peptide names its central problem: poor penetration through intact skin (a permeability measure known as clogP, at -2.24). The same review reports procollagen synthesis increased in 70% of GHK-Cu-treated subjects, against 50% for vitamin C and 40% for retinoic acid, and evaluates two fixes for the penetration problem — a modified, more skin-penetrating form (Pal-GHK) and microneedle pretreatment, which let roughly 134 nanomoles of GHK through skin that otherwise blocked it entirely ^[1].

Skin regeneration, matrix synthesis. A 2015 review of clinical and cell-based studies documents GHK-Cu stimulating collagen, dermatan sulfate, chondroitin sulfate, and the proteoglycan decorin, alongside the same 70%-versus-50%-versus-40% collagen-production comparison against vitamin C and retinoic acid, and links topical use to firmer, more elastic skin with fewer fine lines in placebo-controlled work ^[4].

Hair growth. In a six-month trial of 45 men with pattern hair loss (Norwood-Hamilton stages II through V), a formula combining 5-aminolevulinic acid with GHK increased hair count by 52.6 at a higher concentration and 71.5 at a lower one, against 9.6 for placebo (p<0.05), with no adverse events reported in any group ^[3].

Skin penetration and copper delivery. A 2011 human skin study measured how copper moves through skin as GHK-Cu: a permeability coefficient of 2.43 (±0.51) ×10⁻⁴ cm/h, with 136.2 micrograms of copper per square centimeter crossing over 48 hours and 97 micrograms retained in the dermis as a depot ^[5].

Wound healing, broad profile. A 2008 review compiles GHK-Cu's effects across human and animal wound models: increased synthesis of collagen, elastin, matrix-remodeling enzymes and their inhibitors, VEGF, FGF-2, nerve growth factor, and erythropoietin, alongside suppressed free radicals, inflammatory signaling, and tissue-damaging enzymes, plus active recruitment of repair cells to the wound site ^[6].

Mechanism, dose-response. The foundational 1988 fibroblast study established that collagen synthesis rose with GHK-Cu concentration in a specific, cell-number-independent way — the first direct evidence that the peptide acts as a signal rather than simply increasing cell growth ^[7].

Reported effects, cautions & safety

Reported effects (anecdotal, not clinical evidence): Skincare communities describe a consistent pattern with topical copper-peptide serums. Firmer, tighter-feeling skin is the most common report, building gradually over several weeks of twice-daily use. Softer fine lines follow a similar timeline — six to twelve weeks. Hydration and a plumper look are usually the first change noticed, sometimes within a week or two. Smoother texture and a brighter look come up often. A smaller group reports more even tone and faded marks, though community opinion splits here — some with existing dark spots choose caution instead, since copper feeds the same pigment pathway that Melanotan II activates directly. Scalp users report less shedding and denser-looking hair over three to six months, generally alongside microneedling. A smaller group describes injecting GHK-Cu for systemic effects — these accounts have no validated human data behind them.

On the adverse side, irritation — redness, itching, dryness — is the most frequent complaint, tied to starting too strong or too fast. A subset of acne-prone users report a short breakout ('purging') phase. A minority describe skin looking duller rather than better, nicknamed the 'copper uglies.' Layering copper peptides with vitamin C, strong acids, or retinol is widely reported to cancel the effect or cause irritation, since these actives can strip the copper from the peptide complex.

Cited cautions: Injecting or otherwise taking GHK-Cu systemically is unapproved and has no established human pharmacokinetic basis — it remains experimental outside topical cosmetic use. Repeated systemic copper exposure carries a theoretical accumulation risk, relevant mainly to people with copper-handling conditions such as Wilson's disease; no human copper-toxicity case tied to GHK-Cu appears in the published record. Combining copper peptides with vitamin C or low-pH acids in the same step can break down the copper-peptide complex and should be avoided in formulation and use ^[1]. Most of the human clinical evidence comes from small topical trials, and much of the foundational literature traces to one research group — a reason to read the broader anti-aging claims with some caution ^[1][4].

Where it fits in Skin & Aesthetics

GHK-Cu anchors this desk. It is the only compound of the three with controlled human trials in both its stated use categories — skin appearance and hair growth ^[3][4] — and the only one approved for any human application, as a topical cosmetic ingredient. GLOW carries GHK-Cu's matrix-remodeling rationale into an untested three-peptide blend. Melanotan II works through a completely different pathway — pigment production rather than matrix repair — and carries a far heavier case-report record of harm. See the comparison page for how the evidence quality differs across all three.